Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey

Autor: Sirapa Klinfueng, Somchai Owatanapanich, Jamorn Makaroon, Viboonsak Vuthitanachot, Norra Wutthiratkowit, Siriporn Saelao, Duangporn Asawarachun, Kraisorn Tohtubtiang, Pornsak Yoocharoen, Yong Poovorawan, Preeyaporn Vichaiwattana, Nawarat Posuwan, Apinya Fakthongyoo, Sompong Vongpunsawad, Napha Thanetkongtong, Rujipat Wasitthankasem, Apiradee Theamboonlers, Klaita Srisingh, Monthana Foonoi
Rok vydání: 2016
Předmět:
Male
RNA viruses
0301 basic medicine
Heredity
Physiology
lcsh:Medicine
Blood Donors
Hepacivirus
Geographical Regions
medicine.disease_cause
Geographical Locations
chemistry.chemical_compound
0302 clinical medicine
Seroepidemiologic Studies
Epidemiology
Genotype
Prevalence
Medicine and Health Sciences
Young adult
Child
lcsh:Science
Phylogeny
Pathology and laboratory medicine
Multidisciplinary
Geography
biology
Hepatitis C virus
virus diseases
Hematology
Middle Aged
Medical microbiology
Thailand
Hepatitis C
Body Fluids
Phylogeography
Genetic Mapping
Blood
Biogeography
Child
Preschool

Viruses
RNA
Viral

Female
030211 gastroenterology & hepatology
Pathogens
Anatomy
Antibody
Research Article
Adult
medicine.medical_specialty
Asia
Adolescent
Developing country
Variant Genotypes
Microbiology
Young Adult
03 medical and health sciences
Genetics
medicine
Humans
NS5B
Aged
Evolutionary Biology
Biology and life sciences
Flaviviruses
Population Biology
business.industry
lcsh:R
Ecology and Environmental Sciences
Organisms
Viral pathogens
Infant
Correction
Hepatitis C Antibodies
Virology
Hepatitis viruses
digestive system diseases
Microbial pathogens
Health Care
Regional Geography
030104 developmental biology
chemistry
Age Groups
People and Places
Earth Sciences
biology.protein
lcsh:Q
Population Groupings
business
Population Genetics
Demography
Zdroj: PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0149362 (2016)
ISSN: 1932-6203
Popis: Hepatitis C virus (HCV) infection affects ≥ 180 million individuals worldwide especially those living in developing countries. Recent advances in direct-acting therapeutics promise effective treatments for chronic HCV carriers, but only if the affected individuals are identified. Good treatment coverage therefore requires accurate epidemiological data on HCV infection. In 2014, we determined the current prevalence of HCV in Thailand to assess whether over the past decade the significant number of chronic carriers had changed. In total, 5964 serum samples from Thai residents between 6 months and 71 years of age were obtained from 7 provinces representing all 4 geographical regions of Thailand and screened for the anti-HCV antibody. Positive samples were further analyzed using RT-PCR, sequencing, and phylogenetic analysis to identify the prevailing HCV genotypes. We found that 56 (0.94%) samples tested positive for anti-HCV antibody (mean age = 36.6±17.6 years), while HCV RNA of the core and NS5B subgenomic regions was detected in 23 (41%) and 19 (34%) of the samples, respectively. The seropositive rates appeared to increase with age and peaked in individuals 41-50 years old. These results suggested that approximately 759,000 individuals are currently anti-HCV-positive and that 357,000 individuals have viremic HCV infection. These numbers represent a significant decline in the prevalence of HCV infection. Interestingly, the frequency of genotype 6 variants increased from 8.9% to 34.8%, while the prevalence of genotype 1b declined from 27% to 13%. These most recent comprehensive estimates of HCV burden in Thailand are valuable towards evidence-based treatment coverage for specific population groups, appropriate allocation of resources, and improvement in the national public health policy.
Databáze: OpenAIRE